Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cyclin D1 (CCND1)
100%
Short-term Survival
100%
Cyclin E
100%
Lung Squamous Cell Carcinoma
100%
Non-small Cell Lung Cancer (NSCLC)
70%
Squamous Cell Carcinoma (SqCC)
60%
Immunopositivity
50%
Worse Prognosis
30%
Cyclin
30%
Malignancy
20%
Monoclonal Antibody
20%
Overexpression
20%
San Diego
10%
Immunostaining
10%
Tumor Cells
10%
Prognosis Prediction
10%
Complex Technique
10%
Avidin-biotin Complex
10%
Prognostic Value
10%
Enhanced Sensitivity
10%
Patient with Tumor
10%
Positive Staining
10%
Survival Analysis
10%
Loss of Expression
10%
G1 Phase
10%
Prognostic Marker
10%
Altered Expression
10%
Laryngeal Squamous Cell Carcinoma
10%
Berkeley
10%
Abacus
10%
Kaplan-Meier Survival Plots
10%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Cyclin D1
100%
Cyclin E
100%
Short Term Survival
100%
CD1 Antigen
80%
Non Small Cell Lung Cancer
70%
Cycline
30%
Monoclonal Antibody
20%
Neoplasm
10%
Avidin
10%
Biotin
10%
Immunology and Microbiology
Squamous Cell
100%
Cyclin D1
100%
Cyclin E
100%
Short Term Survival
100%
Cycline
30%
Monoclonal Antibody
20%
Tumor Cell
10%
Immunostaining
10%
Cell Cycle G1 Phase
10%
Biotin
10%
Veterinary Science and Veterinary Medicine
Squamous Cell Carcinoma
100%
Short Term Survival
100%
Non-Small Cell Lung Cancer
87%
Monoclonal Antibody
25%
Cancer
25%
Neoplasm
12%
Avidin-biotin Complex
12%
Larynx
12%
Tumor
12%
Immunohistochemistry
12%